Feb 11, 2021 4:05pm EST ClearPoint Neuro, Inc. Announces Multi-Product Joint Development & Option Agreement with Blackrock Microsystems
Feb 05, 2021 8:00am EST ClearPoint Neuro, Inc. Announces Appointment of R. John Fletcher as Chairman of the Board of Directors
Jan 26, 2021 4:05pm EST ClearPoint Neuro, Inc. Announces Expansion of Pre-Clinical and Translational Development Team to Support Gene and Stem Cell Therapy Partners
Jan 14, 2021 4:05pm EST ClearPoint Neuro, Inc. Announces First Procedure Utilizing ClearPoint® 2.0 Software in Europe
Jan 12, 2021 4:05pm EST ClearPoint Neuro, Inc. Reports Record Revenue in Preliminary Fourth Quarter 2020 Results
Dec 29, 2020 4:15pm EST ClearPoint Neuro, Inc. Announces Funding of Additional $7.5M of Existing Convertible Note on Improved Terms